KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Other Non-Current Assets (2016 - 2025)

Regeneron Pharmaceuticals has reported Other Non-Current Assets over the past 17 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $1.8 billion for Q4 2025, up 60.32% from a year ago — trailing twelve months through Dec 2025 was $1.8 billion (up 60.32% YoY), and the annual figure for FY2025 was $1.8 billion, up 60.32%.
  • Other Non-Current Assets for Q4 2025 was $1.8 billion at Regeneron Pharmaceuticals, up from $1.7 billion in the prior quarter.
  • Over the last five years, Other Non-Current Assets for REGN hit a ceiling of $1.8 billion in Q4 2025 and a floor of $142.9 million in Q2 2021.
  • Median Other Non-Current Assets over the past 5 years was $401.5 million (2023), compared with a mean of $675.2 million.
  • Biggest five-year swings in Other Non-Current Assets: fell 18.58% in 2021 and later soared 196.28% in 2025.
  • Regeneron Pharmaceuticals' Other Non-Current Assets stood at $216.1 million in 2021, then soared by 55.67% to $336.4 million in 2022, then skyrocketed by 32.02% to $444.1 million in 2023, then skyrocketed by 155.8% to $1.1 billion in 2024, then soared by 60.32% to $1.8 billion in 2025.
  • The last three reported values for Other Non-Current Assets were $1.8 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.